Journey Medical Corporation
Price Action
Technical Summary
WEAKENINGJourney Medical Corporation is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 44), showing significant lag compared to the market leaders. Earnings growth of 56% provides fundamental context to the price action. Investors should exercise caution due to high volatility (64% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $6.14 | +4.71% | ABOVE |
| 50 SMA | $5.68 | +13.27% | ABOVE |
| 100 SMA | $6.51 | -1.18% | BELOW |
| 150 SMA | $6.96 | -7.67% | BELOW |
| 200 SMA | $7.13 | -9.78% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is DERM in an uptrend right now?
DERM has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is DERM overbought or oversold?
DERM's RSI (14) is 55. The stock is in neutral territory, neither overbought nor oversold.
Is DERM outperforming the market?
DERM has a Relative Strength (RS) Rating of 44 out of 99. DERM is currently lagging the broader market.
Where is DERM in its 52-week range?
DERM is trading at $6.43, which is 67% of its 52-week high ($9.55) and 40% above its 52-week low ($4.31).
How volatile is DERM?
DERM has a Beta of 1.97 and 52-week volatility of 64%. It's more volatile than the S&P 500 - expect bigger swings.